Clinical Work-Up: Amgen's Trials Move Online

March 1, 2001

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-03-01-2001,

The number of pharmaceuticals in development recently mushroomed, and the complexity of trials is increasing. Amgen has reduced its cycle times but still wants to improve efficiency and cost effectiveness as it enlarges its pipeline, presenting tough new challenges in clinical research.

Related Content:

News